An investigational drug for glioblastoma more than doubled survival and progression-free time compared to standard rates, reported a new study published in Nature Communications. Glioblastoma is the ...
COVID-19 mRNA vaccines significantly increased survival times in patients with advanced lung and skin cancer undergoing immunotherapy. The corresponding study was published in Nature. "The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback